PTK2 and hepatocellular carcinoma: MB Cao (58, 59) discovered that exosome-derived lnc-FAM72D-3 changed the cytoskeleton of HCC by the MBNL1/FAK pathway and hsa_circ_0007132 inhibited the ubiquitin-mediated degradation of NONO, which both increased resistance of Lenvatinib.